IE 11 is a very old Browser and it`s not supported on this site

Performance / Multi-year comparison

Indexed performance since launch (in CHF)

BB Biotech AG (SIX)-CHF
BB BIOTECH AG (XETRA)-EUR
BB BIOTECH AG (MILAN)-EUR
BB Biotech AG (SIX)-CHF
BB BIOTECH AG (XETRA)-EUR
BB BIOTECH AG (MILAN)-EUR

Platzhaltergrafik

Created with Highcharts 8.2.0In %Chart title19952000200520102015202005001000150020002500300035004000

NAV CHF indexed
Share price CHF indexed
Nasdaq Biotech Index (NBI) indexed

Rolling performance

XLS

 

 

SHARE

 

NAV

 

NBI TR

30.06.2020 – 30.06.2021

 

30.9%

 

17.0%

 

17.8%

30.06.2019 – 30.06.2020

 

11.7%

 

20.1%

 

22.3%

28.06.2018 – 28.06.2019

 

4.7%

 

5.6%

 

(0.6%)

29.06.2017 – 29.06.2018

 

20.2%

 

3.1%

 

10.1%

30.06.2016 – 30.06.2017

 

38.3%

 

32.3%

 

18.8%

Annual performance

XLS

 

 

SHARE

 

NAV

 

NBI TR

2020

 

19.3%

 

24.3%

 

15.8%

2019

 

18.5%

 

23.4%

 

23.0%

2018

 

(5.2%)

 

(14.5%)

 

(8.0%)

2017

 

22.9%

 

23.4%

 

16.4%

2016

 

0.2%

 

(19.3%)

 

(20.0%)

Cumulated performance

30.06.2021

XLS

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

22.2%

 

8.9%

 

13.5%

1 year

 

30.9%

 

17.0%

 

17.8%

3 years

 

51.3%

 

46.3%

 

41.5%

5 years

 

148.8%

 

100.8%

 

85.9%

since inception 1)

 

3 502%

 

2 824%

 

1 549%

1 09.11.1993

Annualized performance

30.06.2021

XLS

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

30.9%

 

17.0%

 

17.8%

3 years

 

14.8%

 

13.5%

 

12.3%

5 years

 

20.0%

 

15.0%

 

13.2%

since inception 1)

 

13.8%

 

13.0%

 

10.7%

1 09.11.1993

Platzhaltergrafik

Created with Highcharts 8.2.0In %Chart title200020052010201520200500100015002000250030003500

NAV EUR indexed
Share Price EUR indexed
Nasdaq Biotech Index (NBI) indexed

Rolling performance

XLS

 

 

SHARE

 

NAV

 

NBI TR

30.06.2020 – 30.06.2021

 

26.5%

 

13.5%

 

14.4%

30.06.2019 – 30.06.2020

 

17.0%

 

25.3%

 

27.4%

28.06.2018 – 28.06.2019

 

9.9%

 

9.8%

 

3.5%

29.06.2017 – 29.06.2018

 

13.5%

 

(2.6%)

 

3.9%

30.06.2016 – 30.06.2017

 

35.7%

 

31.0%

 

17.4%

Annual performance

XLS

 

 

SHARE

 

NAV

 

NBI TR

2020

 

18.1%

 

24.8%

 

16.1%

2019

 

23.4%

 

28.1%

 

27.6%

2018

 

(2.2%)

 

(11.1%)

 

(4.3%)

2017

 

12.9%

 

12.5%

 

6.7%

2016

 

1.7%

 

(17.8%)

 

(19.0%)

Cumulated performance

30.06.2021

XLS

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

21.3%

 

7.3%

 

12.0%

1 year

 

26.5%

 

13.5%

 

14.4%

3 years

 

60.1%

 

54.2%

 

49.5%

5 years

 

143.8%

 

98.6%

 

83.5%

since inception 1)

 

2 742%

 

2 214%

 

1 481%

1 10.12.1997

Annualized performance

30.06.2021

XLS

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

26.5%

 

13.5%

 

14.4%

3 years

 

16.9%

 

15.5%

 

14.3%

5 years

 

19.5%

 

14.7%

 

12.9%

since inception 1)

 

15.3%

 

14.3%

 

12.4%

1 10.12.1997

Platzhaltergrafik

Created with Highcharts 8.2.0In %Chart title20052010201520200100200300400500600700

NAV EUR indexed
Share Price EUR indexed
Nasdaq Biotech Index (NBI) indexed

Rolling performance

XLS

 

 

SHARE

 

NAV

 

NBI TR

30.06.2020 – 30.06.2021

 

27.4%

 

13.5%

 

14.4%

30.06.2019 – 30.06.2020

 

15.1%

 

25.3%

 

27.4%

28.06.2018 – 28.06.2019

 

9.8%

 

9.8%

 

3.5%

29.06.2017 – 29.06.2018

 

14.1%

 

(2.6%)

 

3.9%

30.06.2016 – 30.06.2017

 

36.3%

 

31.0%

 

17.4%

Annual performance

XLS

 

 

SHARE

 

NAV

 

NBI TR

2020

 

19.7%

 

24.8%

 

16.1%

2019

 

22.6%

 

28.1%

 

27.6%

2018

 

(1.3%)

 

(11.1%)

 

(4.3%)

2017

 

12.2%

 

12.5%

 

6.7%

2016

 

1.2%

 

(17.8%)

 

(19.0%)

Cumulated performance

30.06.2021

XLS

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

20.3%

 

7.3%

 

12.0%

1 year

 

27.4%

 

13.5%

 

14.4%

3 years

 

59.4%

 

54.2%

 

49.5%

5 years

 

144.5%

 

98.6%

 

83.5%

since inception 1)

 

556%

 

434%

 

210%

1 19.10.2000

Annualized performance

30.06.2021

XLS

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

27.4%

 

13.5%

 

14.4%

3 years

 

16.8%

 

15.5%

 

14.3%

5 years

 

19.6%

 

14.7%

 

12.9%

since inception 1)

 

9.5%

 

8.4%

 

5.6%

1 19.10.2000

Multi-year comparison

XLS

 

 

30.06.2021

 

2020

 

2019

 

2018

 

2017

 

 

Market capitalization at the end of the period (in CHF mn)

 

4 819.8

 

4 107.9

 

3 670.3

 

3 235.4

 

3 576.1

 

toggle chart

Net Asset Value at the end of the period (in CHF mn)

 

4 047.0

 

3 887.5

 

3 393.0

 

2 884.5

 

3 538.7

 

toggle chart

Number of shares (in mn)

 

55.4

 

55.4

 

55.4

 

55.4

 

55.4

 

toggle chart

Trading volume (in CHF mn)

 

1 269.7

 

2 315.6

 

2 004.2

 

2 610.7

 

2 864.7

 

toggle chart

Profit/(loss) (in CHF mn)

 

349.5

 

691.2

 

677.4

 

(471.3)

 

687.5

 

toggle chart

Closing price at the end of the period in CHF

 

87.00

 

74.15

 

66.25

 

58.40

 

64.55

 

toggle chart

Closing price (G) at the end of the period in EUR

 

79.25

 

68.00

 

61.40

 

52.00

 

55.68

 

toggle chart

Closing price (I) at the end of the period in EUR

 

79.20

 

68.50

 

61.00

 

52.00

 

55.20

 

toggle chart

Stock performance (incl. distributions) 1)

 

22.2%

 

19.3%

 

18.5%

 

(5.2%)

 

22.9%

 

toggle chart

High/low share price in CHF

 

92.20/73.40

 

74.70/45.44

 

73.20/59.35

 

74.10/56.10

 

67.80/52.10

 

toggle chart

High/low share price in EUR

 

86.20/67.80

 

69.00/43.04

 

64.70/52.10

 

64.80/48.60

 

59.10/48.42

 

toggle chart

Premium/(discount) (annual average)

 

15.4%

 

9.2%

 

11.8%

 

9.7%

 

(2.5%)

 

toggle chart

Dividend in CHF

 

N.A.

 

3.60

 

3.40

 

3.05

 

3.30

 

toggle chart

Degree of investment (quarterly figures)

 

108.4%

 

106.8%

 

109.1%

 

108.4%

 

103.1%

 

toggle chart

Total Expense Ratio (TER) p.a. 2)

 

1.23%

 

1.25%

 

1.26%

 

1.25%

 

1.27%

 

toggle chart

1 All figures in CHF %, total return-methodology

2 Based on market capitalization

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer